In order to obtain this action we must pay 1,63$ right now, In this post we are going to talk about the listed company Nektar Therapeutics, its leaders are Dimitry S. A. Nuyten (Chief Medical Officer & Senior Vice President), Gilbert M. Labrucherie (Chief Operating & Financial Officer), Howard W. Robin (President, Chief Executive Officer & Director), Jonathan Zalevsky (Chief Research & Development Officer), they lead it to work in Biotechnology: Pharmaceutical Preparations especially in the North America region.
The closing price of the stock yesterday was desconocido$.
With an intraday difference of 1,70$ moving between 1,63$ and 1,76$, it is a notable difference that allows quick purchases and sales.
Their latest annual data shows an income of desconocido.
The opening price that appears as last recorded is desconocido.
One of the most interesting values to assess whether the price of a share is low or high is the minimum and maximum price of the last 52 weeks, in this case it has varied between 0,00$ and 0,00$.
EPS is the net profit that the company has obtained, after paying taxes, divided by the number of total shares it has in circulation. This value is higher the better the company has done, although with some nuances since it can increase if the number of shares for sale decreases, or it can decrease if things that have happened in just a few months are charged annually. For this action the BPA is [BPA].
Buscar
